Volume 20, number 4
 PDF Downloads: 86

Statistical Optimization of Fast Dissolving Tablet Contains Isosorbide Dinitrate for the Treatment of Angina Pectoris

Sabeel Salam1*, Reshma Fathima4 , P. P. Sreelekha3 , M. Kavya5 and E. Anjali2

Department of pharmaceutics, Grace college of pharmacy, Palakkad, Kerala, India.

Corresponding Author E-mail: sabeelsalam1996@gmail.com

DOI : http://dx.doi.org/10.13005/bbra/3183

ABSTRACT: The ultimate objective about this experiment was to create a fast-dissolving tablet Isosorbide dinitrate that released its medication quickly. The physical properties of tablets, such as hardness, angle of repose, weight variation, and friability were assessed. In-vitro release was investigated, and a 22-factorial design was created.  The results show that the in-vitro release shows that the F2 formulation has the highest release at 20 min.  Tablet disintegration time ranges from 31 to 48 s. The hardness ranges from 6-7 kg/cm3. The friability test shows the range from 0.49-0.68%. The weight variation test shows that all the formulation passes the tests. ANOVA statistical analysis revealed that the generated formulations are statistically significant. It is concluded that FDT formulations have optimum and reproducible disintegration time and increased dissolve characteristics, resulting in higher patient compliance.

KEYWORDS: Angina Pectoris; Antianginals; Fast Dissolving Tablet; Isosorbide Dinitrate Therapy; Pharmacotherapy;  Statistical Optimization

Download this article as: 
Copy the following to cite this article:

Salam S, Fathima R, Sreelekha P. P, Kavya M, Anjali E. Statistical Optimization of Fast Dissolving Tablet Contains Isosorbide Dinitrate for the Treatment of Angina Pectoris. Biotech Res Asia 2023;20(4).

Copy the following to cite this URL:

Salam S, Fathima R, Sreelekha P. P, Kavya M, Anjali E. Statistical Optimization of Fast Dissolving Tablet Contains Isosorbide Dinitrate for the Treatment of Angina Pectoris. Biotech Res Asia 2023;20(4). Available from: https://bit.ly/49NWlgO

[ HTML Full Text]

Back to TOC